Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioNeutra Global Corp V.BGA

Alternate Symbol(s):  BGACF

BioNeutra Global Corporation, through its subsidiaries, is involved in the research and development, production and commercialization of food ingredients for nutraceutical, functional and mainstream foods, with a focus on oligosaccharides. Its lead product, VitaFiber IMO is an advanced functional and health food ingredient naturally derived from agricultural products. VitaFiber IMO is naturally sweet and lower in calories than sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health. The Company produces VitaFiber IMO using its patented production processes that naturally transform starch molecules from agriculture cereal crops including tapioca, field pea or corn into the functional health molecules of isomalto-oligosaccharide (IMO). VitaFiber IMO is also available for retail purchase across the globe through Amazon.com and Shopify.com. Its customers include small and medium enterprises and food manufacturers.


TSXV:BGA - Post by User

Post by MrWarrenBuffetton Nov 09, 2019 1:21am
284 Views
Post# 30330760

FDA Interim Response

FDA Interim Response

The FDA issued an Interim Response Letter last week to Top Health Ingredients. It has not reached a decision on their petition. Because of this non-response, Bioneutra looks like it is in trouble for 2020. In less than 8 weeks the company will no longer be able to label or market its products as a fibre in the United States. 

https://www.regulations.gov/document?D=FDA-2019-P-1640-0008

How will this impact IMO sales? How will this impact the company? 

<< Previous
Bullboard Posts
Next >>